ID   ELOV1_HUMAN             Reviewed;         279 AA.
AC   Q9BW60; B4DP24; Q53HT2; Q5JUY3; Q8WXU3; Q9NVD9; Q9Y396;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   12-APR-2017, entry version 138.
DE   RecName: Full=Elongation of very long chain fatty acids protein 1 {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000305};
DE            EC=2.3.1.199 {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000269|PubMed:20166112, ECO:0000269|PubMed:20937905};
DE   AltName: Full=3-keto acyl-CoA synthase ELOVL1 {ECO:0000255|HAMAP-Rule:MF_03201};
DE   AltName: Full=ELOVL fatty acid elongase 1 {ECO:0000255|HAMAP-Rule:MF_03201};
DE            Short=ELOVL FA elongase 1 {ECO:0000255|HAMAP-Rule:MF_03201};
DE   AltName: Full=Very long chain 3-ketoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};
DE   AltName: Full=Very long chain 3-oxoacyl-CoA synthase 1 {ECO:0000255|HAMAP-Rule:MF_03201};
GN   Name=ELOVL1 {ECO:0000255|HAMAP-Rule:MF_03201}; Synonyms=SSC1;
GN   ORFNames=CGI-88;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Asadi A., Jacobsson A.;
RT   "Description of the human SSC1/ELOVL1 gene. Relocation of the CDC20
RT   gene to human chromosome 1 support a bi-directional transcription of
RT   the human SSC1/ELOVL1 and CDC20 genes.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   REVIEW.
RX   PubMed=16564093; DOI=10.1016/j.plipres.2006.01.004;
RA   Jakobsson A., Westerberg R., Jacobsson A.;
RT   "Fatty acid elongases in mammals: their regulation and roles in
RT   metabolism.";
RL   Prog. Lipid Res. 45:237-249(2006).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=20166112; DOI=10.1002/emmm.201000061;
RA   Ofman R., Dijkstra I.M.E., van Roermund C.W.T., Burger N.,
RA   Turkenburg M., van Cruchten A., van Engen C.E., Wanders R.J.A.,
RA   Kemp S.;
RT   "The role of ELOVL1 in very long-chain fatty acid homeostasis and X-
RT   linked adrenoleukodystrophy.";
RL   EMBO Mol. Med. 2:90-97(2010).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INTERACTION WITH LASS2; HSD17B12 AND TECR.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting reaction of the
CC       four that constitute the long-chain fatty acids elongation cycle.
CC       This endoplasmic reticulum-bound enzymatic process, allows the
CC       addition of 2 carbons to the chain of long- and very long-chain
CC       fatty acids/VLCFAs per cycle. Condensing enzyme that exhibits
CC       activity toward saturated C18 to C26 acyl-CoA substrates, with the
CC       highest activity towards C22:0 acyl-CoA. May participate in the
CC       production of both saturated and monounsaturated VLCFAs of
CC       different chain lengths that are involved in multiple biological
CC       processes as precursors of membrane lipids and lipid mediators.
CC       Important for saturated C24:0 and monounsaturated C24:1
CC       sphingolipid synthesis. Indirectly inhibits RPE65 via production
CC       of VLCFAs. {ECO:0000255|HAMAP-Rule:MF_03201,
CC       ECO:0000269|PubMed:20166112, ECO:0000269|PubMed:20937905}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + malonyl-CoA = CoA
CC       + a very-long-chain 3-oxoacyl-CoA + CO(2). {ECO:0000255|HAMAP-
CC       Rule:MF_03201, ECO:0000269|PubMed:20166112,
CC       ECO:0000269|PubMed:20937905}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000269|PubMed:20166112,
CC       ECO:0000269|PubMed:20937905}.
CC   -!- SUBUNIT: Interacts with LASS2, TECR and HSD17B12.
CC       {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000269|PubMed:20937905}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03201, ECO:0000269|PubMed:20937905};
CC       Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03201}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BW60-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BW60-2; Sequence=VSP_045436;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:20937905}.
CC   -!- DOMAIN: The C-terminal di-lysine motif may confer endoplasmic
CC       reticulum localization. {ECO:0000255|HAMAP-Rule:MF_03201}.
CC   -!- SIMILARITY: Belongs to the ELO family. ELOVL1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03201}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34083.1; Type=Frameshift; Positions=189; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF336793; AAL71993.1; -; mRNA.
DR   EMBL; AF151846; AAD34083.1; ALT_FRAME; mRNA.
DR   EMBL; AK001653; BAA91813.1; -; mRNA.
DR   EMBL; AK222498; BAD96218.1; -; mRNA.
DR   EMBL; AK298163; BAG60436.1; -; mRNA.
DR   EMBL; AL139289; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000618; AAH00618.1; -; mRNA.
DR   CCDS; CCDS485.1; -. [Q9BW60-1]
DR   CCDS; CCDS57987.1; -. [Q9BW60-2]
DR   RefSeq; NP_001243328.1; NM_001256399.1. [Q9BW60-1]
DR   RefSeq; NP_001243330.1; NM_001256401.1. [Q9BW60-2]
DR   RefSeq; NP_001243331.1; NM_001256402.1.
DR   RefSeq; NP_073732.1; NM_022821.3. [Q9BW60-1]
DR   UniGene; Hs.25597; -.
DR   ProteinModelPortal; Q9BW60; -.
DR   BioGrid; 122312; 11.
DR   IntAct; Q9BW60; 3.
DR   STRING; 9606.ENSP00000361536; -.
DR   BindingDB; Q9BW60; -.
DR   ChEMBL; CHEMBL6001; -.
DR   SwissLipids; SLP:000000249; -.
DR   iPTMnet; Q9BW60; -.
DR   PhosphoSitePlus; Q9BW60; -.
DR   SwissPalm; Q9BW60; -.
DR   BioMuta; ELOVL1; -.
DR   DMDM; 20137931; -.
DR   EPD; Q9BW60; -.
DR   MaxQB; Q9BW60; -.
DR   PaxDb; Q9BW60; -.
DR   PeptideAtlas; Q9BW60; -.
DR   PRIDE; Q9BW60; -.
DR   TopDownProteomics; Q9BW60-1; -. [Q9BW60-1]
DR   Ensembl; ENST00000372458; ENSP00000361536; ENSG00000066322. [Q9BW60-1]
DR   Ensembl; ENST00000413844; ENSP00000416024; ENSG00000066322. [Q9BW60-2]
DR   Ensembl; ENST00000621943; ENSP00000477602; ENSG00000066322. [Q9BW60-1]
DR   GeneID; 64834; -.
DR   KEGG; hsa:64834; -.
DR   UCSC; uc001cjb.5; human. [Q9BW60-1]
DR   CTD; 64834; -.
DR   DisGeNET; 64834; -.
DR   GeneCards; ELOVL1; -.
DR   GeneCards; MIR6734; -.
DR   H-InvDB; HIX0000507; -.
DR   HGNC; HGNC:14418; ELOVL1.
DR   HPA; CAB033426; -.
DR   HPA; HPA056557; -.
DR   MIM; 611813; gene.
DR   neXtProt; NX_Q9BW60; -.
DR   OpenTargets; ENSG00000066322; -.
DR   PharmGKB; PA27760; -.
DR   eggNOG; KOG3071; Eukaryota.
DR   eggNOG; ENOG410XRWT; LUCA.
DR   GeneTree; ENSGT00760000119122; -.
DR   HOGENOM; HOG000038120; -.
DR   HOVERGEN; HBG051468; -.
DR   InParanoid; Q9BW60; -.
DR   KO; K10247; -.
DR   OMA; LYQEMMK; -.
DR   OrthoDB; EOG091G0N2V; -.
DR   PhylomeDB; Q9BW60; -.
DR   TreeFam; TF323454; -.
DR   Reactome; R-HSA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   ChiTaRS; ELOVL1; human.
DR   GenomeRNAi; 64834; -.
DR   PRO; PR:Q9BW60; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000066322; -.
DR   CleanEx; HS_ELOVL1; -.
DR   Genevisible; Q9BW60; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0102336; F:3-oxo-arachidoyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102337; F:3-oxo-cerotoyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102338; F:3-oxo-lignoceronyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009922; F:fatty acid elongase activity; IDA:UniProtKB.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; TAS:Reactome.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_03201; VLCF_elongase_1; 1.
DR   InterPro; IPR030457; ELO_CS.
DR   InterPro; IPR002076; ELO_fam.
DR   InterPro; IPR033681; ELOVL1.
DR   PANTHER; PTHR11157; PTHR11157; 1.
DR   Pfam; PF01151; ELO; 1.
DR   PROSITE; PS01188; ELO; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    279       Elongation of very long chain fatty acids
FT                                protein 1.
FT                                /FTId=PRO_0000207536.
FT   TRANSMEM     23     43       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   TRANSMEM     61     81       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   TRANSMEM    110    130       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   TRANSMEM    137    154       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   TRANSMEM    176    196       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   TRANSMEM    201    221       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   TRANSMEM    231    251       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   MOTIF       275    279       Di-lysine motif. {ECO:0000255|HAMAP-
FT                                Rule:MF_03201}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:25944712}.
FT   VAR_SEQ      80    106       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045436.
FT   CONFLICT     68     68       S -> P (in Ref. 3; BAA91813).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       Y -> H (in Ref. 1; AAL71993).
FT                                {ECO:0000305}.
FT   CONFLICT    201    201       M -> T (in Ref. 3; BAD96218).
FT                                {ECO:0000305}.
SQ   SEQUENCE   279 AA;  32663 MW;  B168EE4C7EAF92A6 CRC64;
     MEAVVNLYQE VMKHADPRIQ GYPLMGSPLL MTSILLTYVY FVLSLGPRIM ANRKPFQLRG
     FMIVYNFSLV ALSLYIVYEF LMSGWLSTYT WRCDPVDYSN SPEALRMVRV AWLFLFSKFI
     ELMDTVIFIL RKKDGQVTFL HVFHHSVLPW SWWWGVKIAP GGMGSFHAMI NSSVHVIMYL
     YYGLSAFGPV AQPYLWWKKH MTAIQLIQFV LVSLHISQYY FMSSCNYQYP VIIHLIWMYG
     TIFFMLFSNF WYHSYTKGKR LPRALQQNGA PGIAKVKAN
//
